Articole cu mandate pentru acces public - Brian LeberAflați mai multe
Nu sunt disponibile nicăieri: 7
Acute myeloid leukaemia disrupts endogenous myelo-erythropoiesis by compromising the adipocyte bone marrow niche
AL Boyd, JC Reid, KR Salci, L Aslostovar, YD Benoit, Z Shapovalova, ...
Nature cell biology 19 (11), 1336-1347, 2017
Mandate: Canadian Cancer Society, Canadian Institutes of Health Research, Fonds de …
Phase II multicenter study of oblimersen sodium, a Bcl‐2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B‐cell non‐Hodgkin lymphoma
B Pro, B Leber, M Smith, L Fayad, J Romaguera, F Hagemeister, ...
British journal of haematology 143 (3), 355-360, 2008
Mandate: US National Institutes of Health
O-GlcNAc-glycosylation of β-catenin regulates its nuclear localization and transcriptional activity
R Sayat, B Leber, V Grubac, L Wiltshire, S Persad
Experimental cell research 314 (15), 2774-2787, 2008
Mandate: Canadian Institutes of Health Research
Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an MDS‐CAN prospective study
R Buckstein, RA Wells, N Zhu, HA Leitch, TJ Nevill, KWL Yee, B Leber, ...
British journal of haematology 174 (1), 88-101, 2016
Mandate: Canadian Institutes of Health Research
Overall survival in lower IPSS risk MDS by receipt of iron chelation therapy, adjusting for patient‐related factors and measuring from time of first red blood cell transfusion …
HA Leitch, A Parmar, RA Wells, L Chodirker, N Zhu, TJ Nevill, KWL Yee, ...
British journal of haematology 179 (1), 83-97, 2017
Mandate: Canadian Institutes of Health Research
Unleashing blocked apoptosis in cancer cells: new MCL1 inhibitors find their groove
B Leber, J Kale, DW Andrews
Cancer Discovery 8 (12), 1511-1514, 2018
Mandate: Canadian Institutes of Health Research
The successful management of acute promyelocytic leukemia during pregnancy: a case report
B Salter, JM Radford, T Berg, B Leber
Leukemia & Lymphoma 65 (4), 526-529, 2024
Mandate: Ontario Institute for Cancer Research
Disponibile undeva: 60
Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax
JF Lovell, LP Billen, S Bindner, A Shamas-Din, C Fradin, B Leber, ...
Cell 135 (6), 1074-1084, 2008
Mandate: Canadian Institutes of Health Research
Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells
E Sachlos, RM Risueño, S Laronde, Z Shapovalova, JH Lee, J Russell, ...
Cell 149 (6), 1284-1297, 2012
Mandate: Canadian Institutes of Health Research
BH3-only proteins: Orchestrators of apoptosis
A Shamas-Din, H Brahmbhatt, B Leber, DW Andrews
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1813 (4), 508-520, 2011
Mandate: Canadian Institutes of Health Research
Bcl-XL inhibits membrane permeabilization by competing with Bax
LP Billen, CL Kokoski, JF Lovell, B Leber, DW Andrews
PLoS biology 6 (6), e147, 2008
Mandate: Canadian Institutes of Health Research
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
DJ DeAngelo, KE Stevenson, SE Dahlberg, LB Silverman, S Couban, ...
Leukemia 29 (3), 526-534, 2015
Mandate: US National Institutes of Health
Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin
S Assouline, B Culjkovic, E Cocolakis, C Rousseau, N Beslu, A Amri, ...
Blood 114 (2), 257-260, 2009
Mandate: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy
CJ Owen, CL Toze, A Koochin, DL Forrest, CA Smith, JM Stevens, ...
Blood, The Journal of the American Society of Hematology 112 (12), 4639-4645, 2008
Mandate: Cancer Research UK
Still embedded together binding to membranes regulates Bcl-2 protein interactions
B Leber, J Lin, DW Andrews
Oncogene 29 (38), 5221-5230, 2010
Mandate: US National Institutes of Health, Canadian Institutes of Health Research
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
HA Zahreddine, B Culjkovic-Kraljacic, S Assouline, P Gendron, ...
Nature 511 (7507), 90-93, 2014
Mandate: US National Institutes of Health
Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence
AL Boyd, L Aslostovar, J Reid, W Ye, B Tanasijevic, DP Porras, ...
Cancer cell 34 (3), 483-498. e5, 2018
Mandate: Canadian Cancer Society, Canadian Institutes of Health Research, Natural …
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
S Oppermann, J Ylanko, Y Shi, S Hariharan, CC Oakes, PM Brauer, ...
Blood, The Journal of the American Society of Hematology 128 (7), 934-947, 2016
Mandate: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Drugs targeting Bcl-2 family members as an emerging strategy in cancer
B Leber, F Geng, J Kale, DW Andrews
Expert reviews in molecular medicine 12, e28, 2010
Mandate: Canadian Institutes of Health Research, Ontario Institute for Cancer Research
tBid undergoes multiple conformational changes at the membrane required for Bax activation
A Shamas-Din, S Bindner, W Zhu, Y Zaltsman, C Campbell, A Gross, ...
Journal of Biological Chemistry 288 (30), 22111-22127, 2013
Mandate: Canadian Institutes of Health Research
Informațiile despre publicații și finanțare sunt alese automat de un program informatic